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Abstract We describe the cloning, expression, and localization
of Q2-adaptin, a novel isoform of Q-adaptin. The predicted human
and mouse Q2-adaptin proteins are V90 kDa and 64.4% and
61.7% identical to Q-adaptin, respectively. Q2-Adaptin was
localized to the Golgi, its localization distinct from Q-adaptin.
The membrane association of Q- and Q2-adaptin could further be
distinguished by differential sensitivity to the fungal metabolite
brefeldin A, Q2-adaptin binding being insensitive to drug
treatment. Together, these results suggest that Q2-adaptin plays
a role in membrane transport distinct from that played by
Q-adaptin.
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1. Introduction
Intracellular membrane tra⁄c in eukaryotic cells is typi¢ed
by the budding of transport vesicles from progenitor mem-
branes and the subsequent fusion of vesicles with target mem-
branes. The mechanism of transport vesicle budding must
confer the vesicle’s identity as de¢ned by its cargo and the
components required for vesicle targeting and fusion upon
reaching its destination. Vesicle budding typically requires re-
cruitment of cytosolic coat proteins, such as clathrin, COPI,
and COPII. These coat proteins interact directly and indi-
rectly with integral membrane proteins at the bud site, and
are likely to participate in the selection of cargo (reviewed in
[1^3]).
Clathrin is the best characterized coat protein involved in
the formation of transport vesicles. The clathrin-mediated for-
mation of transport vesicles from the plasma membrane and
trans-Golgi network requires the activity of multi-component
adaptor protein (AP) complexes to recruit clathrin to the cy-
tosolic face of these membranes. The AP-1 complex recruits
clathrin to the TGN and AP-2 recruits clathrin to the plasma
membrane (reviewed in [4]). A third adaptor complex, termed
AP-3, is also found on the TGN, as well as on peripheral
cytoplasmic foci, that may correspond to endosomal struc-
tures [5,6]. This adaptor complex may be a component of a
non-clathrin coat [6], although a recent study has shown that
it can associate with clathrin [7].
Adaptors are heterotetrameric structures consisting of two
heavy chains termed ‘adaptins’ and one each of a medium (W)
and small (c) chain. The AP-1 adaptor complex associated
with clathrin coats on the TGN consists of two adaptins (Q-
and L1-adaptin) of V100 kDa, W1 (V47 kDa), and c1 (V19
kDa). AP-2, the plasma membrane adaptor, is also comprised
of two adaptins (K- and L2-adaptin, each V100 kDa), W2
(V50 kDa), and c2 (V17 kDa). The AP-3 heterotetramer
has two somewhat larger adaptin subunits, N- and L3-adaptin
(V140 kDa and V160 kDa), W3 (V47 kDa), and c3 (V22
kDa). There are neuron speci¢c isoforms of the AP-2 and AP-
3 adaptor complexes containing neuronal-speci¢c adaptins, W
chains, and c chains. All adaptor complexes have a similar
overall structure consisting of an N-terminal, block-like,
‘head’ domain, a hydrophilic, usually proline and glycine-
rich, ‘hinge’ domain, followed by a C-terminal ‘ear’ domain
[4^6,8].
AP-1 and AP-2 recruit clathrin and participate in molecular
sorting [3]. AP-1 and AP-3 are thought to mediate transport
from the TGN to the endocytic pathway; the corresponding
activity for AP-2 is from the plasma membrane to the endo-
some. Clathrin on early endosomes is also likely to participate
in molecular sorting at this organelle. However, until recently
[7] none of the known adaptor complexes were found associ-
ated with clathrin on endosomes [3,6,9,10]. The role of W and
c chains in adaptor complexes has been discussed extensively
elsewhere [4].
There are at least twelve well characterized sorting events in
intracellular membrane tra⁄cking described in eukaryotic
cells [4]. Notably, there are more pathways than coat proteins
to account for them. This observation, and the assumption
that molecular sorting must require a protein coat [1,2,4,11],
prompted us to search for novel adaptin molecules. Here we
report the cDNA cloning and initial characterization of a
novel, ubiquitously expressed, Q-adaptin-like molecule, we
term ‘Q2-adaptin’.
2. Materials and methods
2.1. Cell lines, antibodies, and reagents
HeLa cells were grown on plastic tissue culture plates in MEM,
heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin, 10 Wg/
ml streptomycin, 2 mM L-glutamine, at 37‡C in 5% CO2. Fluorescent
secondary antibodies were from Jackson ImmunoResearch Laborato-
ries. Partial human cDNAs were from the American Type Culture
Collection (Rockville, MD, USA). An oligo(dT) primed mouse em-
bryonic brain VZAPII cDNA library was generously provided by M.
Tiemeyer (Yale University School of Medicine, New Haven, CT,
USA). All molecular biology reagents were purchased from New Eng-
land Biolabs (Beverly, MA, USA), unless otherwise noted. Brefeldin
A was from Epicenter Technologies (Madison, WI, USA). Mouse
monoclonal anti-Q-adaptin (100/3) and FITC-labeled Helix pomatia
lectin were purchased from Sigma (St. Louis, MO, USA). Monoclonal
anti-L-COP was generously provided by T. Kreis, University of Gen-
eva, Geneva, Switzerland. Chemical ¢xatives for electron microscopy
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were obtained from Electron Microscope Sciences (Ft. Washington,
PA, USA), protein A-gold conjugates were purchased from J.W. Slot,
The University of Utrecht (Cell Biology, Utrecht, The Netherlands).
All other chemicals for electron microscopy were obtained from Sig-
ma, St. Louis, MO, USA.
2.2. Database searches, sequencing, and sequence analysis
An NCBI BLAST search of the EST databases using the published
mouse Q-adaptin cDNA as the query sequence (GenBank accession
number X54424) was performed. The mouse Q2-adaptin was cloned
using array cloning [12]. Primers were derived from a mouse EST
(GenBank accession number AA185250) corresponding to the 3P
end of mouse Q2-adaptin. The T49401 partial human cDNA of human
Q2-adaptin was used as a probe for Southern analysis for array clon-
ing. A 78-bp gap corresponding to amino acids 189^215 in the open
reading frame of the mouse Q2-adaptin was cloned by RT-PCR of
mouse ¢rst strand cDNA from thymus. PCR was performed using
PLATINUM Taq DNA polymerase as per the manufacturer’s instruc-
tions (Life Technologies, Gaithersburg, MD, USA). Con¢rmation of
the amino acid sequence of mouse Q2-adaptin was generously provided
by H. Cen and R. Williams (Chiron, Emeryville, CA, USA). The full-
length cDNAs for both the mouse and the human Q2-adaptins were
toxic to bacteria and could not be maintained as complete cDNAs.
Sequence analysis and compilation of sequencing information was
performed using LaserGene Navigator (DNAStar, Madison, WI,
USA). Sequencing of both strands of cDNAs was done by the
W.M. Keck Foundation Biotechnology Resource Laboratory, Yale
University, New Haven, CT, USA. Oligos were obtained from the
Program for Critical Technologies in Molecular Medicine, Yale Uni-
versity, New Haven, CT, USA.
2.3. Northern analysis
Northern analysis of a multiple human mRNA (Clontech, Palo
Alto, CA, USA) was performed as per the manufacturer’s instructions
using [K-32P]dCTP-labeled (Amersham, Arlington Heights, IL, USA),
random primed, Q2-adaptin cDNAs (ESTs T49401 and H41406), or
control L-actin, as probes prepared according to the manufacturer’s
instructions (Stratagene, La Jolla, CA, USA). Blots were stripped and
reprobed as recommended by the manufacturer. Images were acquired
using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA)
or Hyper¢lm MP (Amersham, Arlington Heights, IL, USA).
2.4. Peptides and antibody production
Peptides for antibody production, a⁄nity puri¢cation, and peptide
competition experiments were: N-LEKVLQSHMSLPA-C (Q2-adap-
tin) and N-LESVLISNMSTSV-C (mouse Q-adaptin), see Fig. 1b. Pep-
tides were obtained from the W.M. Keck Foundation Biotechnology
Resource Laboratory, HHMI, Yale University, New Haven, CT,
USA. The Q2-adaptin peptide was glutaraldehyde conjugated to
KLH (Pierce, Rockford, IL, USA). The KLH-Q2-adaptin peptide con-
jugate was used to immunize rabbits (Pocono Rabbit Farm, Cana-
densis, PA, USA). Where required, polyclonal anti-peptide antibodies
were a⁄nity puri¢ed from crude serum using Q2-adaptin peptide con-
jugated to tresyl chloride-activated agarose (Sigma, St. Louis, MO,
USA). Crude anti-Q2-adaptin peptide antiserum was used for all ex-
periments, unless otherwise stated.
2.5. Immuno£uorescence microscopy and peptide competition
HeLa cells were cultured on glass coverslips for 24^48 h as de-
scribed [13]. Peptide competition of the binding of a⁄nity puri¢ed
anti-Q2-adaptin peptide antibody was performed by pre-incubating
V50 Wg/ml primary antibodies in the presence of 20 Wg/ml Q2-adaptin
peptide, or the corresponding peptide from mouse Q-adaptin peptide,
on ice for 45 min prior to addition to the coverslip. Cells were visual-
ized using a Zeiss Axiophot £uorescence microscope with a rhod-
amine and £uorescein ¢lter set. Photographic images were scanned
from 35-mm black and white negatives using a Polaroid SprintScan35
scanner (Cambridge, MA, USA), then processed in parallel using
Adobe Photoshop 4.0 (Mountain View, CA, USA).
2.6. Electron microscopy
HeLa cells were grown for 72 h on plastic substrate and ¢xed 1 h in
4% bu¡ered formaldehyde containing 0.2% glutaraldehyde (pH 7.4).
Double strength ¢xative was added to cells and medium at 37‡C, left
for 5 min and then replaced with fresh single strength ¢xative and left
for 1 h on ice. The ¢xative was replaced with PBS/10% FCS, the cells
scraped and pelleted. Cell pellets were embedded in 10% gelatin, in-
fused in 2.3 M sucrose, frozen in liquid nitrogen, and sectioned in an
Ultracut S ultramicrotome (Leica, Deer¢eld, IL, USA) at 3110‡C to
3130‡C using a diamond knife (DiatomeU.S., Ft. Washington, PA,
USA). Sections were handled and immunolabeled using established
methods [14,15].
3. Results
3.1. Molecular cloning and sequence analysis of human and
mouse cDNAs encoding Q2-adaptin
Using mouse Q-adaptin (X54424) [16] as our probe in a
TBLASTN search of dbest [17], we identi¢ed four overlapping
human ESTs (T49401, T80403, H41406, and AA0051855) that
together comprised a 3.312-kb nucleotide sequence consisting
of 5P-UTR, 2.256 kb of open reading frame, and 3P-UTR
(GenBank accession AF068706). A TBLASTN 2.0 search of
the mouse dbest [18] using the translated open reading frame
of this human Q-adaptin homolog recovered a single signi¢-
cant EST (AA185250) coding for the 29 C-terminal amino
acids and 0.25 kb of 3P-UTR for the corresponding mouse
Q-adaptin homolog. The full length cDNA (GenBank acces-
sion AF068706) was cloned using an array of a mouse embry-
onic brain cDNA library.
The novel human and mouse sequences clearly fall within
the Q-adaptin sub-family of the adaptin family of proteins
(Fig. 1a). Indeed, their high degree of homology to Q-adaptin
led us to designate them ‘Q2-adaptin’. The human and mouse
Q2-adaptin cDNAs encode proteins of 786 amino acids (V87
kDa) and 791 amino acids (V88 kDa), respectively, that are
86.5% identical and 88.2% similar. Mouse Q2-adaptin is 61.7%
identical and 70% similar to mouse Q-adaptin, and human Q2-
adaptin is 64.4% identical and 73.1% similar to mouse Q-adap-
tin. The highest degree of homology is in the head domains of
Q- and Q2-adaptin, and like most of the members of the adap-
tin family, the hinge domain of Q2-adaptin is proline- and
glycine-rich relative to other regions of the molecule (Fig.
1b). Though both Q- and Q2-adaptin have an overall similarity
of sequence and structure, Q2-adaptin has a truncated ‘ear’
domain (Fig. 1c), which is the shortest of all the mammalian
adaptins identi¢ed (data not shown). The reduction of the ear
domain in Q2-adaptin may have functional signi¢cance in that
the ear domain of K-adaptin has been shown to interact with
Eps15, a molecule that is found on the periphery of coated
pits on the plasma membrane (see Section 4) [19^23].
3.2. Tissue distribution of Q2-adaptin in mouse and human
tissues
Human tissues were examined by Northern analysis to de-
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Fig. 1. Analysis of predicted amino acid sequences of Q2-adaptins
and tissue distribution. a: A dendrogram showing the relationship
between representative known adaptins (see [4] for accession num-
bers). b: Alignment of Q2-adaptins, and human Q2-adaptin. Identical
residues are highlighted. Boxed peptides for anti-Q2-adaptin antise-
rum and peptide competition experiments. The underlined sequence
is the ‘WIIDGY’ domain found in adaptin molecules [6]. c: Kyte-
Doolittle hydropathy plots of Q-adaptins divided into three domains:
Head, Hinge, and Ear. d: Northern analysis showing ubiquitous ex-
pression of Q2-adaptin. The central column of numbers are the mo-
lecular weight markers and 28S and 18S ribosomal subunits. Molec-
ular weights of messages revealed using the Q2-adaptin probe on
outer sides of the blots.
D.A. Lewin et al./FEBS Letters 435 (1998) 263^268264
termine the expression pattern of Q2-adaptin (Fig. 1d). North-
ern analysis revealed equally abundant 2.6- and 3.7-kb mes-
sages; the 2.6-kb message may represent an abundant splicing
intermediate. Interestingly, Northern analysis of message from
brain revealed the primary message for Q2-adaptin to be V8
kb, suggesting a brain-speci¢c isoform of Q2-adaptin. North-
ern analysis (Fig. 1d) and RT-PCR (data not shown) demon-
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Fig. 2. Peptide competition and colocalization of Q2-adaptin with
Golgi markers. Indirect immuno£uorescence of HeLa cells using af-
¢nity puri¢ed Q2-adaptin peptide antibodies molecule reveals a Gol-
gi-like perinuclear staining pattern (a, b phase) that can be com-
peted for with the Q2-adaptin peptide (c, d phase). Colocalization of
Q2-adaptin (e, g, i) compared to Q-adaptin (f), FITC-labeled Helix
pomatia lectin (h), and L-COP (j). Arrows indicate perinuclear re-
gion of cells where there is little colocalization between Q2- and
Q-adaptin. Arrowheads indicate areas of colocalization between
Q2-adaptin and FITC-HPL.
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strated that the Q2-adaptin message was ubiquitously ex-
pressed.
3.3. Cellular localization, di¡erential brefeldin A sensitivity,
and relative distribution of Q2-adaptin vs. Q-adaptin
Several peptides derived from the predicted amino acid se-
quences of human and mouse Q2-adaptin were used to gener-
ate antisera. One peptide (N-LEKVLQSHMSLPA-C, see box
Fig. 1b) generated an antiserum suitable for immuno£uores-
cence and immunoelectron microscopy in HeLa cells, as well
as all other mammalian cell lines examined (mouse, rat, ham-
ster, and canine ^ data not shown). Unfortunately, this anti-
serum proved to be unsuitable for Western analysis and im-
munoprecipitation of endogenous proteins from cell lysates.
Both crude antiserum and a⁄nity puri¢ed antibodies to the
Q2-adaptin peptide reveal a strong perinuclear, Golgi-like,
staining pattern (Fig. 2). To be certain that this pattern was
not a cross-reaction, we performed a peptide competition as-
say with the immunizing peptide and the corresponding pep-
tide from Q-adaptin (Fig. 1b). The Q2-adaptin peptide com-
pletely inhibited antibody recognition of Q2-adaptin in HeLa
cells (Fig. 2a) while the corresponding Q-adaptin peptide had
no e¡ect on the staining of this Golgi-like structure (Fig. 2b).
A comparable result was observed in a mouse cell line (data
not shown).
Association of Q-adaptin to Golgi membranes is sensitive to
the fungal metabolite brefeldin A (BFA) [24,25]. When BFA is
added to cells in vivo the majority of Q-adaptin rapidly be-
comes cytosolic (V2 min). L-COP, a component of ‘coatom-
er’, a Golgi-associated coat protein complex involved in
vesicle budding [1,2], has the same reversible BFA sensitivity
as Q-adaptin. However, BFA has little e¡ect upon the distri-
bution of K-adaptin [24]. To test whether Q2-adaptin’s behav-
ior was more like that of L-COP and Q-adaptin, or that of
K-adaptin, BFA was added to HeLa cells grown on coverslips.
The localization of Q2-adaptin was compared to that of
Q-adaptin after 15 min in 10 WM BFA-supplemented growth
media. Q2-Adaptin remains membrane bound in the presence
of BFA (Fig. 3a) while Q-adaptin (Fig. 3b) and L-COP (data
not shown) dissociate from membranes. These data provide
additional evidence in support of Q2-adaptin being a unique
entity distinct from Q-adaptin.
We next examined the intracellular distribution of Q2-adap-
tin relative to a number of markers of the secretory pathway
including Q-adaptin (Fig. 2e,f). Though there was partial co-
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Fig. 4. Immunogold electron microscopic localization of Q2- and
Q-adaptin. Frozen thin sections were prepared from HeLa cells and
labeled with antibodies against Q2-adaptin and Q-adaptin. a: Golgi
stacks (G) label with Q2-adaptin (10 nm gold) and with Q-adaptin
(5 nm gold). Bar = 0.5 Wm. b: Higher magni¢cation of Golgi stacks
in a. Bar = 0.25 Wm. c: Vesicular structures with electron-dense coat-
like material are positive for Q2-adaptin (5 nm gold) and Q-adaptin
(10 nm gold). Bar = 0.5 Wm. Inset in c is higher magni¢cation view
of boxed region.
Fig. 3. Q2-Adaptin in HeLa cells has a di¡erential sensitivity to bre-
feldin A compared to Q-adaptin. HeLa cells were double labeled for
Q2-adaptin and Q-adaptin. See Fig. 2 for colocalization of Q2-adaptin
and Q-adaptin. a, b: After 15 min of exposure to BFA, Q2-adaptin
remains associated with membranes while Q-adaptin becomes cyto-
solic. Inset: Note association of Q2-adaptin staining with probable
Golgi-membrane tubules.
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localization with a number of markers, including Q-adaptin,
the best colocalization with Q2-adaptin was observed for a cis-
Golgi/intermediate compartment marker, FITC-labeled Helix
pomatia lectin (FITC-HPL) [26] (Fig. 2g,h). In addition to the
colocalization with FITC-HPL, Q2-adaptin also colocalized
with L-COP (Fig. 2i,j), a marker of the ER and Golgi appa-
ratus [1,2,24]. The peripheral punctate staining pattern ob-
served in cells stained for Q2-adaptin did not correspond to
endocytic structures as determined by immuno£uorescent
comparison with early endocytic and recycling compartments
(FITC-labeled human transferrin) [13], late endosomes (man-
nose 6-phosphate receptor), lysosomes (lysosomal glycopro-
tein, lgp95) [27] (data not shown).
Immunoelectron microscopy of HeLa cells con¢rmed the
distinct localizations of Q- and Q2-adaptin in the Golgi appa-
ratus. Q2-Adaptin labeling was found to be associated with
vesicles of the Golgi complex, and occasionally with Golgi
cisternae (Fig. 4a,b). Although antibody to Q-adaptin labeled
membrane structures in close proximity to those positive for
Q2-adaptin, where membranes were clearly discernible, labeling
was exclusive for one or the other adaptin. Interestingly, an
electron-dense coat structure appeared to surround vesicles
that were positive for either Q- or Q2-adaptin (Fig. 4c). At least
in the case of Q-adaptin, this coat is likely to re£ect the pres-
ence of clathrin [28].
4. Discussion
In this study we describe a novel member of the adaptin
family, Q2-adaptin, identi¢ed based upon its similarity to the
AP-1 adaptor protein, Q-adaptin. This adaptin is widely ex-
pressed in both human and murine tissues, as well as in a
number of cell lines from other species. In addition, it is
possible that there is a brain-speci¢c isoform of Q2-adaptin.
Q2-Adaptin is found on the Golgi apparatus, both on Golgi
stacks as well as on vesicular structures in close proximity to
vesicles labeling for Q-adaptin in the TGN (Fig. 4).
There is a high degree of sequence similarity between Q- and
Q2-adaptin (s 60%). However, Q2-adaptin has a truncated ear
domain compared to Q-adaptin, although the amino acid sim-
ilarity between Q2-adaptin and Q-adaptin remains high in the
regions where the ear domains of the two adaptins align. This
may be signi¢cant because the ear domain of K-adaptin inter-
acts with the epidermal growth factor receptor tyrosine kinase
substrate Eps15 which, given its localization in nascent cla-
thrin-coated pits at the plasma membrane and its primary
structure, is suggestive of a role in the regulation of the for-
mation of clathrin-coated vesicles [19^23]. It is possible that
the ear domains of other adaptins also interact with Eps15-
like molecules. Therefore, the structural di¡erences between
the ear domains of Q- and Q2-adaptin may re£ect functional
di¡erences between these molecules.
The di¡erential sensitivity of Q-adaptin and Q2-adaptin to
the fungal metabolite brefeldin A suggests di¡erent mecha-
nisms for regulation of the recruitment of these two adaptins
to membranes. Recruitment of Q-adaptin as a component of
the AP-1 adaptor, and the subsequent recruitment of clathrin,
to the TGN depends upon the activity of the small GTP-bind-
ing protein, ARF1. ARF proteins are recruited to membranes
in their GTP-bound conformation. BFA inhibits the exchange
of GDP for GTP on ARFs, thus maintaining them in their
inactive, cytosolic, conformation [29,30]. In the presence of
BFA coat protein components, both Q-adaptin as part of the
AP-1/clathrin coat and the L-COP-containing coatomer com-
plex, rapidly become cytosolic [2,24]. In contrast, Q2-adaptin
remains associated with Golgi membranes in the presence of
BFA (Fig. 3), even after extended periods (2 h) in the presence
of the drug (data not shown). This result suggests that the
Q2-adaptin membrane association may be regulated by a
di¡erent ARF GTPase than Q-adaptin, or by an altogether
di¡erent regulatory mechanism [24].
There is a high degree of colocalization between Q2-adaptin
and the Golgi markers L-COP and Helix pomatia lectin (Fig.
2). This and the presence of Q2-adaptin on the stacks of the
Golgi as well as on vesicles closely associated with vesicles
positive for Q-adaptin (Fig. 4), suggests that this adaptin
may play a more general role in the tra⁄cking of molecules
through the secretory pathway. Q-Adaptin in the TGN is in-
volved in the sorting of integral membrane proteins from the
TGN to the late endosome and its presence on this structure is
indicative of the binding of clathrin [25,27,28,31^33]. Q2-Adap-
tin has a wider distribution than Q-adaptin at the electron
microscopic level.
The localization of the novel Q2-adaptin to a distinct pop-
ulation of membranes with electron-dense material present
around vesicles, distinct from those membranes populated
by the clathrin-recruiting Q-adaptin, suggests that there may
be a novel coat protein associated with Q2-adaptin-containing
membranes. The AP-3 adaptor complex found on the TGN
associated with vesicular structures in close proximity to cla-
thrin-coated vesicles does not colocalize with clathrin in the
Golgi apparatus [6,34], though AP-3 on endocytic structures
appears to do so [7]. This observation suggests that there are
more classes of vesicles whose contents are determined by the
activity of adaptors in the Golgi apparatus and associated
structures. It is possible that both Q-adaptin and Q2-adaptin
are capable of recruiting clathrin to membranes and that the
di¡erences in localization between these molecules re£ect a
di¡erence in vesicle cargo. Further investigation will be re-
quired to understand the signi¢cance of the structural di¡er-
ences between Q2- and Q-adaptin, potential di¡erences between
the components of the AP-1 adaptor and the putative
Q2-adaptin-associated adaptor, and the additional heterogene-
ity of vesicles associated with the Golgi apparatus.
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